FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
HEMATOLOGY
PAPER II
HEMAT/D/16/48/II
Time 3 hours
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. What are the causes of lymphocytosis?
What are the causes of lymphocytopenia?
How do you test for clonality of viruses that can cause
lymphocytosis?

2. Enumerate the diseases where iron overload has an impact.
Tests and procedures to estimate iron overload.
Treatment options for iron overload.

3. What are blood component?
How do you prepare them?
How do you use blood components in critically ill patients?

4. What are transfusion related complications?
Problems and solutions in immune cytopenias: Role of
transfusion of blood products.
Principles of blood compatibility testing.

5. In CLL:
What are the stages and prognosis?
What is the preferred treatment for younger patients?
What are the options for untreated older patients?

6. In a bone marrow study, explain with examples the importance of:
Bone marrow aspirate.
Bone marrow biopsy.
Special tests on aspirate.
Special tests on biopsy.
Technical issues in the bone marrow aspirate and biopsy.

P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
HEMATOLOGY
PAPER II
7. Classify Hodgkin's disease.
Staging of Hodgkin's disease.
PET/CET adapted treatment in Hodgkin's disease.
Fertility preservation in Hodgkin's disease survivors.

8. In survivors of non- Hodgkin's lymphoma, what are the strategies
for:
Monitoring for relapse
Monitoring for complications
Maintenance therapy

9. In febrile neutropenia:
How do you assess risk?
Importance of fungal markers.
Importance of imaging.

10. In pregnancy and thrombosis:
How do you choose anti-coagulants in first trimester?
How do you manage heparin induced thrombocytopenia?
Advice at labour and delivery.